SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001657312-24-000005
Filing Date
2024-02-29
Accepted
2024-02-29 06:08:57
Documents
16
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrna-20240229.htm   iXBRL 8-K 39130
2 EX-99.1 vrna10k2023pressrelease.htm EX-99.1 80925
6 GRAPHIC new_veronacorpxlogoxinline.jpg GRAPHIC 394217
  Complete submission text file 0001657312-24-000005.txt   768537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20240229.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20240229_lab.xml EX-101.LAB 24635
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20240229_pre.xml EX-101.PRE 12988
17 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20240229_htm.xml XML 2977
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 24698626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)